Richmond pharmaceutical company Kaléo Inc. has been tapped by federal agencies to develop a countermeasure to nerve-agent poisoning. A contract from the Biomedical Advanced Research and Development ...
A St. Louis-area manufacturing plant, which has served as a key supplier of an antidote to sarin nerve gas for the military and civilian first responders, has suspended production due to ...
Richmond pharmaceutical company Kaléo Inc. has tapped Theresa Matkovits to be its new chief development officer. Matkovits, who was most recently chief development officer at Bedminster, New Jersey’s ...